Uncategorized

Trends to Follow for Medical Clinics

Laura Landro had an interesting article in the Wall Street Journal this morning talking about the growth of alternative clinics: retail, work, urgent care.   She quotes a study by Renee Hsia that shows patients seeking emergency care rose by 43% from 2000-2009 while hospital emergency room visits declined 27% over the same period.

The trend is compelling for clinic operators interested in bringing services closer to patients.  Wal-Mart recently announced plans to re-expand into this space.   Currently, much of the expansion has been into retail locations (pharmacies, department stores) that see a stream of customers for other products.  However, this article also says that about 300 new urgent care clinics are opening each year.

These developments present opportunities and challenges for clinics seeking to compete for patients.  Patient acceptance of the "quick care" model in lieu of scheduled office visits or ER visits opens the potential for more patients in clinics that adopt new models for serving these customers.  As competition increases, pressure on pricing and available services will also increase.  Maintaining a broad suite of services, like medication dispensing, as well as adjustments in hours, scheduling and staffing will help clinics remain competitive.

Though these trends aren’t new, they may be accelerating.  The health care law and growing price pressures will continue to push patients and payers to creative solutions to today’s complex healthcare challenges.

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading